158 related articles for article (PubMed ID: 26616174)
1. Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration.
He J; Wang K; Zheng N; Qiu Y; Xie G; Su M; Jia W; Li H
Sci Rep; 2015 Nov; 5():17423. PubMed ID: 26616174
[TBL] [Abstract][Full Text] [Related]
2. Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems.
Udhane SS; Legeza B; Marti N; Hertig D; Diserens G; Nuoffer JM; Vermathen P; Flück CE
Sci Rep; 2017 Aug; 7(1):8652. PubMed ID: 28819133
[TBL] [Abstract][Full Text] [Related]
3. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2).
Madsen A; Bozickovic O; Bjune JI; Mellgren G; Sagen JV
Sci Rep; 2015 Nov; 5():16430. PubMed ID: 26548416
[TBL] [Abstract][Full Text] [Related]
5. Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer.
Lord SR; Cheng WC; Liu D; Gaude E; Haider S; Metcalf T; Patel N; Teoh EJ; Gleeson F; Bradley K; Wigfield S; Zois C; McGowan DR; Ah-See ML; Thompson AM; Sharma A; Bidaut L; Pollak M; Roy PG; Karpe F; James T; English R; Adams RF; Campo L; Ayers L; Snell C; Roxanis I; Frezza C; Fenwick JD; Buffa FM; Harris AL
Cell Metab; 2018 Nov; 28(5):679-688.e4. PubMed ID: 30244975
[TBL] [Abstract][Full Text] [Related]
6. Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells.
Zheng N; Wang K; He J; Qiu Y; Xie G; Su M; Jia W; Li H
Sci Rep; 2016 May; 6():25892. PubMed ID: 27180883
[TBL] [Abstract][Full Text] [Related]
7. Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.
Cuyàs E; Fernández-Arroyo S; Alarcón T; Lupu R; Joven J; Menendez JA
Oncotarget; 2016 Aug; 7(33):52974-52992. PubMed ID: 27259235
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Approaches to Investigate the Effect of Metformin: An Overview.
Kim HW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638615
[TBL] [Abstract][Full Text] [Related]
9. Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways.
Zheng Z; Xu L; Zhang S; Li W; Tou F; He Q; Rao J; Shen Q
Oncotarget; 2017 Jul; 8(29):47619-47631. PubMed ID: 28496003
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cells.
Repas J; Zügner E; Gole B; Bizjak M; Potočnik U; Magnes C; Pavlin M
Sci Rep; 2021 Nov; 11(1):21354. PubMed ID: 34725457
[TBL] [Abstract][Full Text] [Related]
11. Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication.
Ouyang J; Feng Y; Zhang Y; Liu Y; Li S; Wang J; Tan L; Zou L
Biomed Pharmacother; 2023 Dec; 168():115659. PubMed ID: 37864896
[TBL] [Abstract][Full Text] [Related]
12. Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells.
Islam SR; Manna SK
Metabolomics; 2024 Feb; 20(2):29. PubMed ID: 38413541
[TBL] [Abstract][Full Text] [Related]
13. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin.
Heishi M; Ichihara J; Teramoto R; Itakura Y; Hayashi K; Ishikawa H; Gomi H; Sakai J; Kanaoka M; Taiji M; Kimura T
Diabetologia; 2006 Jul; 49(7):1647-55. PubMed ID: 16752183
[TBL] [Abstract][Full Text] [Related]
15. Metformin turns off the metabolic switch of pancreatic cancer.
Deschênes-Simard X; Rowell MC; Ferbeyre G
Aging (Albany NY); 2019 Dec; 11(23):10793-10795. PubMed ID: 31831715
[No Abstract] [Full Text] [Related]
16. Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin.
Xue C; Wang C; Liu Q; Meng Q; Sun H; Huo X; Ma X; Liu Z; Ma X; Peng J; Liu K
Tumour Biol; 2016 Jul; 37(7):8587-97. PubMed ID: 26733176
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer.
Moon HS; Mantzoros CS
Endocr Relat Cancer; 2013 Dec; 20(6):849-59. PubMed ID: 24157941
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective Effects of Metalaxyl Enantiomers on Breast Cancer Cells Metabolic Profiling Using HPLC-QTOF-Based Metabolomics.
Zhang P; Zhu W; Wang D; Yan J; Wang Y; He L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085117
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Microarray Expression Studies on Metformin in Cancer Cell Lines.
Schulten HJ; Bakhashab S
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261735
[TBL] [Abstract][Full Text] [Related]
20. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
